Pharmaceuticals
Novo Nordisk expands discounted Wegovy to all cash-paying U.S. customers
Jakub Porzycki | Nurphoto | Getty Images Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a discounted price of $499 per month at their local pharmacy. U.S.-listed shares of Novo fell more than 2.5% to $74.92 in premarket trading. Novo has also lost its spot […]
Read More
Novo Nordisk’s next-gen obesity drug CagriSema had investors excited. Now they’re not so sure
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Novo Nordisk‘s hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from […]
Read More
Why startups and tech giants are racing to build a practical quantum computer
Technology giants Amazon, IBM, Google, Intel and Microsoft are all working on quantum technology, as are various other companies like Rigetti, IonQ, Quantum Computing Inc. and D-Wave Quantum Inc. The latest entrant into the space is Nvidia, with CEO Jensen Huang announcing in March that the company will build a quantum computing research center in […]
Read More
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn’t look like much has changed. Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active ingredient in Zepbound. Some, […]
Read More
White House pulls Trump’s nomination for CDC director hours before confirmation hearing
Former Congressman Dave Weldon addresses a small crowd in The Villages, Fla. Brendan Farrington | AP The White House has pulled President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, former Rep. Dave Weldon, the Senate’s Health committee confirmed Thursday. The move came just hours before the former Florida lawmaker, a […]
Read More
Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Danish biotech Zealand Pharma’s obesity drug candidate, as the two firms seek to compete in the burgeoning weight loss drug market. The deal will see the two companies co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as […]
Read More
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their […]
Read More
RFK Jr. could further deter childhood vaccinations as rates fall in the U.S.
Robert F. Kennedy Jr. speaks in the Oval Office of the White House, on the day he is sworn in as secretary of Health and Human Service in Washington, D.C., U.S., Feb. 13, 2025. Nathan Howard | Reuters The nation’s new top health official could further erode already falling U.S. vaccination rates against once-common childhood […]
Read More
Walgreens to go private in roughly $10 billion deal with Sycamore Partners
The Walgreens logo is displayed at a Walgreens store on October 15, 2024 in San Rafael, California. Justin Sullivan | Getty Images Struggling drugstore chain Walgreens is going private. The company on Thursday said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity […]
Read More
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients […]
Read More